Location History:
- Boston, MA (US) (2021)
- Belmont, NH (US) (2018 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Sylvie Breton: Innovator in Renal Inflammation Detection and Treatment
Introduction
Sylvie Breton is a notable inventor based in Belmont, NH (US), recognized for her contributions to the field of medical diagnostics and treatment. With a total of five patents to her name, she has made significant strides in the detection and treatment of renal inflammation.
Latest Patents
Among her latest patents is a groundbreaking method for detecting and treating inflammation. This patent focuses on assays and methods for identifying renal inflammation by measuring the levels of P2Y14 and/or UDP-glucose in biological samples, such as urine. Additionally, she has developed methods for treating renal inflammation through the administration of a P2Y14 inhibitor. Another significant patent involves assays and methods for detecting UDP-glucose, which are designed to be compatible with standard clinical laboratory equipment. These methods allow for rapid and reproducible detection of UDP-glucose at physiologically relevant levels in biological samples.
Career Highlights
Sylvie Breton is currently associated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work has been instrumental in enhancing the understanding and management of renal inflammation, contributing to better patient outcomes.
Collaborations
Some of her notable coworkers include Dennis Brown and Anie Azroyan, who have collaborated with her on various projects aimed at improving medical diagnostics.
Conclusion
Sylvie Breton's innovative work in the field of renal inflammation detection and treatment exemplifies her commitment to advancing medical science. Her patents reflect her dedication to improving healthcare through innovative solutions.